Meningococcal Vaccine and Other Product Development 2010 - 2018
Description
The UK is supporting a Product Development Partnership (PDP), the Meningitis Vaccine Project to develop a polyvalent meningitis vaccine for Sub-Saharan Africa that will control the remaining 15% to 20% of meningococcal infections not covered by the existing Maningitis A Vaccine.
Location
The country, countries or regions that benefit from this Programme.
Status Post-completion
The current stage of the Programme, consistent with the International Aid Transparency Initiative's (IATI) classifications.
Programme Spend
Programme budget and spend to date, as per the amounts loaded in financial system(s), and for which procurement has been finalised.
Participating Organisation(s)
Help with participating organisations
Accountable:Organisation responsible for oversight of the activity
Extending: Organisation that manages the budget on behalf of the funding organisation.
Funding: Organisation which provides funds.
Implementing: Organisations implementing the activity.
- Accountable
- Funding
- Implementing
Sectors
Sector groups as a percentage of total Programme budget according to the OECD Development Assistance Committee (DAC) classifications.
Budget
A comparison across financial years of forecast budget and spend to date on the Programme.
Download IATI Data for GB-1-202045